GIC joins consortium to invest US$418 mil in biopharmaceutical company I-MAB

Singapore’s sovereign wealth fund, GIC, has joined a consortium of investors to invest US$418 million ($570.2 million), in clinical stage biopharmaceutical company I-MAB.

Labour market

New PCP launched in Singapore biopharm industry, to benefit 300 over the next year: Manpower Minister Teo

A new Professional Conversion Programme has been launched for Advanced Biopharmaceuticals Manufacturing Professionals and Executives in the biopharmaceutical manufacturing industry subsec

Global biopharma giant AbbVie opens first Asia manufacturing facility in Singapore

SINGAPORE (Sept 29): Global biopharmaceutical giant, AbbVie has opened its new small molecule active pharmaceutical ingredient (API) facility in Singapore, marking its first manufacturing facility

Be informed of the stories that matter